Lab
P.R. Clinical Reference Laboratory INC
P.R. Clinical Reference Laboratory INC was paid $3.66M by Medicaid between Jan 2018 and Dec 2024, across 80 billing codes. Its largest line is 87635, Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe — 20% of everything it billed.
33Billing provider infoP.R. CLINICAL REFERENCE LABORATORY INC
VEGA BAJA, PR 00693
VEGA BAJA, PR 00693
33aNPI1932102167assigned 05/23/2005
33bProvider typeClinical Medical Laboratory
28Total paid$3.66M
24GClaims240,592
24DCodes billed80
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#16 of 777
Median peer was paid$278K
This provider vs. median13×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 34,609 | $329K | |
| 2019 | 27,487 | $272K | |
| 2020 | 31,623 | $569K | |
| 2021 | 41,136 | $938K | |
| 2022 | 35,713 | $694K | |
| 2023 | 38,862 | $493K | |
| 2024incomplete | 31,162 | $369K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 20% | 14,650 | 12,887 | $730K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 14% | 21,222 | 18,260 | $507K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 9.6% | 8,753 | 7,989 | $352K |
| 84443 | Thyroid stimulating hormone (TSH) | 7.6% | 17,793 | 17,213 | $278K |
| 80061 | Lipid panel | 6.0% | 17,703 | 17,093 | $221K |
| 80053 | Comprehensive metabolic panel | 5.3% | 19,947 | 18,986 | $195K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.8% | 24,299 | 22,713 | $176K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 4.3% | 5,724 | 5,527 | $158K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.4% | 6,835 | 5,407 | $123K |
| 86738 | 2.4% | 6,840 | 6,399 | $87K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 2.4% | 9,612 | 9,310 | $87K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1.8% | 3,000 | 2,869 | $67K |
68 more codes
| 86328 | 1.8% | 2,858 | $65K | |
| 81000 | 1.7% | 21,412 | $63K | |
| 82274 | 1.4% | 3,471 | $51K | |
| 84153 | 1.3% | 2,709 | $46K | |
| 80074 | 1.1% | 903 | $41K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.1% | 1,242 | $39K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,020 | $35K |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,911 | $32K |
| 85027 | <1% | 5,302 | $31K | |
| 84439 | <1% | 3,085 | $28K | |
| 87088 | <1% | 3,287 | $24K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,995 | $23K |
| 82607 | <1% | 1,591 | $22K | |
| 82043 | <1% | 3,916 | $22K | |
| 84436 | <1% | 3,132 | $20K | |
| 84479 | <1% | 2,834 | $17K | |
| 83970 | <1% | 252 | $10K | |
| 85730 | <1% | 1,785 | $10K | |
| 86592 | <1% | 2,343 | $9K | |
| 82570 | <1% | 1,833 | $9K | |
| 86038 | <1% | 755 | $9K | |
| 85651 | <1% | 2,199 | $7K | |
| 85610 | <1% | 1,857 | $7K | |
| 87276 | <1% | 597 | $7K | |
| 87275 | <1% | 600 | $6K | |
| 86696 | <1% | 269 | $5K | |
| 86140 | <1% | 945 | $4K | |
| 82270 | <1% | 1,131 | $4K | |
| 83001 | <1% | 185 | $3K | |
| 86695 | <1% | 225 | $3K | |
| 86803 | <1% | 197 | $3K | |
| 80069 | <1% | 215 | $2K | |
| 86376 | <1% | 131 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 195 | $2K |
| 82947 | <1% | 429 | $2K | |
| 84403 | <1% | 63 | $2K | |
| 82670 | <1% | 54 | $1K | |
| 84550 | <1% | 339 | $1K | |
| 82728 | <1% | 105 | $1K | |
| 82950 | <1% | 314 | $1K | |
| 82378 | <1% | 69 | $1K | |
| 83655 | <1% | 97 | $1K | |
| 82951 | <1% | 95 | $1K | |
| 86800 | <1% | 67 | $945.68 | |
| 84703 | <1% | 117 | $820.17 | |
| 84156 | <1% | 205 | $721.51 | |
| 87177 | <1% | 104 | $650.87 | |
| 83550 | <1% | 76 | $643.43 | |
| 84160 | <1% | 115 | $520.75 | |
| 86430 | <1% | 102 | $510.83 | |
| 86769 | <1% | 16 | $462.86 | |
| 86003 | <1% | 15 | $435.90 | |
| 82105 | <1% | 24 | $382.53 | |
| 87338 | <1% | 27 | $359.14 | |
| 84100 | <1% | 77 | $349.17 | |
| 82746 | <1% | 26 | $343.97 | |
| 82952 | <1% | 83 | $335.83 | |
| 84481 | <1% | 18 | $308.18 | |
| 84146 | <1% | 17 | $293.68 | |
| 83540 | <1% | 39 | $235.40 | |
| 80050 | General health panel | <1% | 18 | $174.76 |
| 86161 | <1% | 14 | $165.19 | |
| 86694 | <1% | 12 | $165.02 | |
| 82465 | <1% | 40 | $163.50 | |
| 86160 | <1% | 12 | $142.29 | |
| 80076 | <1% | 17 | $128.60 | |
| 87340 | <1% | 13 | $107.32 | |
| 84478 | <1% | 13 | $69.95 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGONZALEZ, CARLOS (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Stars Speech INC. | Chula Vista, CA | $2.30M |
| ST. Thomas Clinical Reference Laboratory | St Thomas, VI | $708K |
| Puerto Rico Clinical Reference Laboratory | Manati, PR | $380K |
| Broadway Internal Medicine P.C | Elmhurts, NY | $31K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.